GLYCOMIMETICS INC Contracts & Agreements
75 Contracts & Agreements
- Business Finance (16 contracts)
- Business Operations (5)
- Human Resources (40)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Real Estate (5)
- Uncategorized (6)
- Consulting Agreement, dated as of July 31, 2024, by and between the Registrant and Edwin Rock (Filed With SEC on November 13, 2024)
- Separation Agreement, dated as of July 30, 2024, by and between the Registrant and Edwin Rock (Filed With SEC on November 13, 2024)
- Retention Agreement, dated as of August 7, 2024, by and between the Registrant and Brian Hahn (Filed With SEC on November 13, 2024)
- Retention Agreement, dated as of August 7, 2024, by and between the Registrant and Harout Semerjian (Filed With SEC on November 13, 2024)
- Form of GlycoMimetics Securities Purchase Agreement (Filed With SEC on October 29, 2024)
- Form of GlycoMimetics Support Agreement (Filed With SEC on October 29, 2024)
- Form of Crescent Support Agreement (Filed With SEC on October 29, 2024)
- Agreement and Plan of Merger and Reorganization, dated as of October 28, 2024, by and among GlycoMimetics Biopharma, Inc., Gemini Merger Sub Corp., Gemini Merger Sub II, LLC and... (Filed With SEC on October 29, 2024)
- Form of Registration Rights Agreement (Filed With SEC on October 29, 2024)
- Form of Lock-Up Agreement (Filed With SEC on October 29, 2024)
- Amended and Restated Non-Employee Director Compensation Policy, as currently in effect (Filed With SEC on March 27, 2024)
- Second Amendment to Lease, dated April 20, 2018, by and between the Registrant and BMR-Medical Center Drive LLC (Filed With SEC on March 27, 2024)
- Project Agreement dated January 2, 2024 with Patheon Manufacturing Services LLC, part of Thermo Fisher Scientific (Filed With SEC on March 27, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 3, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 2, 2023)
- Transition Agreement dated February 21, 2023, by and between the Company and John Magnani, Ph.D (Filed With SEC on May 3, 2023)
- Consulting Agreement dated March 31, 2023, by and between the Company and John Magnani, Ph.D (Filed With SEC on May 3, 2023)
- Executive Employment Agreement, dated as of February 16, 2022, by and between the Registrant and Bruce Johnson (Filed With SEC on May 3, 2023)
- Executive Employment Agreement, dated as of February 10, 2023, by and between the Registrant and Chinmaya Rath (Filed With SEC on May 3, 2023)
- Release Agreement, dated February 13, 2023, by and between the Company and Armand Girard (Filed With SEC on May 3, 2023)
- Third Amendment to Lease Agreement, dated April 19, 2023, by and between GlycoMimetics, Inc. and ARE-Maryland No. 45, LLC (Filed With SEC on April 21, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 29, 2023)
- Executive Employment Agreement, dated as of August 31, 2022, by and between the Registrant and Edwin Rock, M.D (Filed With SEC on November 9, 2022)
- GlycoMimetics, Inc. Amended and Restated 2013 Equity Incentive Plan (Filed With SEC on May 20, 2022)
- Sales Agreement, dated April 28, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on April 28, 2022)
- GlycoMimetics, Inc. Amended and Restated Inducement Plan dated as of January 21, 2022 (Filed With SEC on March 3, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 3, 2022)
- Consulting Agreement, dated as of August 31, 2021, by and between the Registrant and Rachel King (Filed With SEC on March 3, 2022)
- Executive Employment Agreement, effective as of August 3, 2021, by and between the Registrant and Harout Semerjian (Filed With SEC on November 2, 2021)
- Amended and Restated Executive Employment Agreement, effective as of February 19, 2021, by and between the Registrant and Eric Feldman (Filed With SEC on August 5, 2021)
- Sales Agreement, dated October 7, 2020, by and between the Company and Cowen and Company, LLC (Filed With SEC on October 7, 2020)
- Collaboration and License Agreement, dated January 2, 2020, by and between the Registrant and Apollomics (Hong Kong) Limited (Filed With SEC on February 28, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
- GlycoMimetics, Inc. Inducement Plan (Filed With SEC on February 28, 2020)
- Description of Certain of Registrants Securities (Filed With SEC on February 28, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Rachel K. King (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Brian M. Hahn (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and John Magnani, Ph.D (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Helen Thackray (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of July 30, 2019, by and between the Registrant and Armand Girard (Filed With SEC on August 1, 2019)
- Amended and Restated Executive Employment Agreement, effective as of March 1, 2019, by and between the Registrant and Armand Girard (Filed With SEC on May 2, 2019)
- Underwriting Agreement by and among GlycoMimetics, Inc., Jefferies LLC and Cowen and Company, LLC, dated March 20, 2018 (Filed With SEC on March 21, 2018)
- 7,000,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on May 25, 2017)
- 3,300,000 Shares GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 17, 2016)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 29, 2016)
- GLYCOMIMETICS, INC. common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on March 1, 2016)
- LEASE by and between BMR-MEDICAL CENTER DRIVE LLC, aDelaware limited liability company and GLYCOMIMETICS, INC., a Delawarecorporation TABLE OF CONTENTS (Filed With SEC on July 28, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)
- GLYCOMIMETICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on December 20, 2013)
- LICENSE AGREEMENT (Filed With SEC on October 31, 2013)
- GLYCOMIMETICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on October 28, 2013)
- [Number of Shares] GlycoMimetics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: OCTOBER 25, 2013 (Filed With SEC on October 28, 2013)
- GLYCOMIMETICS, INC. 2013EQUITY INCENTIVE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: OCTOBER 25, 2013 EFFECTIVE DATE: [],2013 (Filed With SEC on October 28, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2013EMPLOYEE STOCK PURCHASE PLAN ADOPTEDBY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS: [], 2013 (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2013EQUITY INCENTIVE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: SEPTEMBER 19, 2013 APPROVED BY THE STOCKHOLDERS:[], 2013 EFFECTIVEDATE: [], 2013 (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC 2003 STOCK INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2003 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. 2003 STOCK INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- GLYCOMIMETICS, INC. Common Stock Purchase Warrant (Filed With SEC on October 4, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 4, 2013)
- LEASE AGREEMENT (Filed With SEC on October 4, 2013)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 4, 2013)
- LICENSE AGREEMENT between GLYCOMIMETICS, INC. and PFIZER INC. dated as of October 7, 2011 Table of Contents (Filed With SEC on October 4, 2013)
